Xinjun Liang
Impact in
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis
- Lymphatic System and Diseases
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes
Papers in
- Oncology 26
- Inflammatory Biomarkers in Disease Prognosis 8
- Colorectal Cancer Treatments and Studies 4
- Pancreatic and Hepatic Oncology Research 4
- Lymphatic System and Diseases 3
- HER2/EGFR in Cancer Research 3
- Cancer Treatment and Pharmacology 3
- Cancer Immunotherapy and Biomarkers 3
-
- Cancer, Lipids, and Metabolism 6
- Co-authors
- Yanyan Liu (9 shared papers)Yueqiang Li (4 shared papers)Gang Xu (5 shared papers)Ying Zhang (3 shared papers)Haotian Wei (4 shared papers)Yifei Ma (10 shared papers)Shaozhong Wei (13 shared papers)Ping Lü (9 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Frontiers in Oncology (5 papers)Journal of Inflammation Research (2 papers)Frontiers in Molecular Biosciences (2 papers)BioMed Research International (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Xinjun Liang
44 papers receiving 550 citations
Peers
Comparison fields: 5 of 84
- Oncology 205
- Nephrology 51
- Immunology 93
- Cancer Research 54
- Pathology and Forensic Medicine 55
Countries citing papers authored by Xinjun Liang
This map shows the geographic impact of Xinjun Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinjun Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinjun Liang more than expected).
Fields of papers citing papers by Xinjun Liang
This network shows the impact of papers produced by Xinjun Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinjun Liang. The network helps show where Xinjun Liang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xinjun Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 81 | |
| 2 | 2021 | 58 | |
| 3 | 2019 | 43 | |
| 4 | 2018 | 40 | |
| 5 | 2020 | 26 | |
| 6 | 2012 | 25 | |
| 7 | 2022 | 19 | |
| 8 | 2017 | 19 | |
| 9 | 2021 | 17 | |
| 10 | 2019 | 17 | |
| 11 | 2014 | 15 | |
| 12 | 2021 | 14 | |
| 13 | 2020 | 13 | |
| 14 | 2019 | 12 | |
| 15 | 2021 | 12 | |
| 16 | 2021 | 11 | |
| 17 | 2022 | 11 | |
| 18 | 2022 | 10 | |
| 19 | 2022 | 9 | |
| 20 | 2023 | 9 |
About Xinjun Liang
Xinjun Liang is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 45 papers that have together received 557 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (8 papers), Cancer, Lipids, and Metabolism (6 papers), Colorectal Cancer Treatments and Studies (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Lymphatic System and Diseases (3 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Oncology (205 citations), Nephrology (51 citations), Immunology (93 citations), Cancer Research (54 citations) and Pathology and Forensic Medicine (55 citations). Xinjun Liang has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yanyan Liu, Yueqiang Li, Gang Xu, Ying Zhang, Haotian Wei, Yifei Ma, Shaozhong Wei, Ping Lü, Kun Wang and Kun Wang. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Journal of Inflammation Research, Frontiers in Molecular Biosciences and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.